Agilent Technologies Inc Quick Ratio (A) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Agilent Technologies inc   (NYSE: A)

Agilent Technologies Inc 's Quick Ratio

A's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.77 below Agilent Technologies Inc average.

Within Laboratory Analytical Instruments industry 14 other companies have achieved higher Quick Ratio than Agilent Technologies Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 2002 to 2046.

Explain Quick Ratio?
How much Cash & cash equivalents A´s has?
What are A´s Current Liabilities?




A Quick Ratio (Jul 31 2026)
Q3
(Apr 30 2026)
Q2
(Jan 31 2026)
Q1
(Oct 31 2025)
Q4
(Jul 31 2025)
Q3
Y / Y Current Liabilities Change 45.43 % 34.02 % 50.84 % 50.74 % -25.4 %
Y / Y Cash & cash equivalent Change 14.53 % 21.6 % 34.61 % 34.61 % -13.72 %
Quick Ratio MRQ 0.77 0.8 0.76 0.76 0.98
A's Total Ranking # 2046 # 2002 # 1970 # 1779 # 1644
Seq. Current Liabilities Change 0.88 % -3.32 % 0 % 49.11 % -7.03 %
Seq. Cash & cash equivalent Change -2.71 % 1.01 % 0 % 16.55 % 3.3 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 15
Healthcare Sector # 678
Overall Market # 2046


Quick Ratio Statistics
High Average Low
2.43 1.39 0.56
(Jul 31 2015)   (Jul 31 2022)




Financial Statements
Agilent Technologies Inc 's Current Liabilities $ 2,289 Millions Visit A's Balance sheet
Agilent Technologies Inc 's Cash & cash equivalent $ 1,758 Millions Visit A's Balance sheet
Source of A's Sales Visit A's Sales by Geography


Cumulative Agilent Technologies Inc 's Quick Ratio

A's Quick Ratio for the trailling 12 Months

A Quick Ratio

(Jul 31 2026)
12 Months
(Apr 30 2026)
12 Months
(Jan 31 2026)
12 Months
(Oct 31 2025)
12 Months
(Jul 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 45.02 % 23.44 % 15.61 % 8.77 % -0.22 %
Y / Y Cash & cash equivalent TTM Growth 25.78 % 16.83 % 8.04 % -3.61 % -14.34 %
Quick Ratio TTM 0.77 0.81 0.83 0.86 0.89
Total Ranking TTM # 4052 # 3172 # 1989 # 3220 # 3039
Seq. Current Liabilities TTM Growth 8.38 % 7.24 % 11.03 % 12.38 % -7.75 %
Seq. Cash & cash equivalent TTM Growth 3.22 % 4.86 % 7.49 % 8.1 % -4.12 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $2,289.00 millions, cumulative Quick Ratio decreased to 0.77 below the Agilent Technologies Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Agilent Technologies Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3172 to 4052.

Explain Quick Ratio?
How much Cash & cash equivalents A´s has?
What are A´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 23
Healthcare Sector # 907
Within the Market # 4052


trailing twelve months Quick Ratio Statistics
High Average Low
2.16 1.35 0.61
(Jul 31 2015)   (Jan 31 2023)




Companies with similar Quick Ratio in the quarter ending Jul 31 2026, within Laboratory Analytical Instruments Industry Quick RatioJul 31 2026 MRQ Cash & cash equivalentJul 31 2026 MRQ Current Liabilities
Quanterix Corporation  1.86 $ 93.529  Millions$ 50.373  Millions
Nautilus Biotechnology Inc   1.52 $ 13.166  Millions$ 8.639  Millions
Rapid Micro Biosystems Inc   1.13 $ 20.500  Millions$ 18.150  Millions
Bionano Genomics Inc   1.04 $ 10.420  Millions$ 10.039  Millions
Bio rad Laboratories Inc   0.92 $ 886.900  Millions$ 961.300  Millions
Precipio inc   0.83 $ 3.075  Millions$ 3.701  Millions
Lifeloc Technologies Inc   0.83 $ 0.908  Millions$ 1.099  Millions
Agilent Technologies inc   0.77 $ 1,758.000  Millions$ 2,289.000  Millions
Revvity Inc  0.67 $ 1,022.943  Millions$ 1,516.157  Millions
Harvard Bioscience Inc   0.26 $ 6.503  Millions$ 24.793  Millions
Waters Corporation  0.22 $ 539.000  Millions$ 2,399.000  Millions
Kewaunee Scientific Corporation  0.22 $ 10.261  Millions$ 47.235  Millions
Bruker Corporation  0.18 $ 217.200  Millions$ 1,204.700  Millions

Date modified: 2026-09-26T07:19:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.